The similarities in metabolic signature between liability to type 2 diabetes and fasting insulin, but not other glycemic traits, imply signals associated with type 2 diabetes liability are likely the result of elevated insulin in response to insulin resistance instead of overall hyperglycemia. Here, INS is linked to type 2 diabetes mellitus.